You have read all your free articles, to continue reading subscribe to read the rest of this content.
In an interview in Nordic Life Science, the Head of AstraZeneca's Oncology Business unit, shared his insights on current drug development within oncology and how we can create faster access to innovative medicines. “Drug development within oncology has evolved to become more flexible,” said DAlready a subscriber Login You have…
Mads Krogsgaard Thomsen, Executive Vice President and Chief Science Officer at Novo Nordisk, talks about the Danish pharma giant’s drug-development strategy, the new era of diabetes care and his 25 year-long passion for his job. The changing diabetes market, with increasing competition and highAlready a subscriber Login You have read…
Dr. William Haseltine is specifically renowned for his pioneering work on cancer, HIV/AIDS and genomics. Through all of his undertakings, he has always kept the ultimate goal of curing the world's populations from diseases in mind. 2507Already a subscriber Login You have read all your free articles, to continue reading…
Like sports, R&D requires team spirit, commitment, and a long view says Dr. Jan Lundberg, Lilly executive vice president for science and technology, and president of Lilly Research Laboratories. Dr. Jan Lundberg’s online bios and YouTube videos portray a steely pharmaceutical executive whosAlready a subscriber Login You have read all…
[…] Read more: Interview with Peter Zerhouni, CEO, InDex Pharmaceuticals […]